The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Cancer Development, Progression, and Therapy: An Epigenetic Overview
Open accessAbstract
Carcinogenesis involves uncontrolled cell growth, which follows the activation of oncogenes and/or the deactivation of tumor suppression genes. Metastasis requires down-regulation of cell adhesion receptors necessary for tissue-specific, cell–cell attachment, as well as up-regulation of receptors that enhance cell motility. Epigenetic changes, including histone modifications, DNA methylation, and DNA hydroxymethylation, can modify these characteristics. Targets for these epigenetic changes include signaling pathways that regulate apoptosis and autophagy, as well as microRNA. We propose that predisposed normal cells convert to cancer progenitor cells that, after growing, undergo an epithelial-mesenchymal transition. This process, which is partially under epigenetic control, can create a metastatic form of both progenitor and full-fledged cancer cells, after which metastasis to a distant location may occur. Identification of epigenetic regulatory mechanisms has provided potential therapeutic avenues. In particular, epigenetic drugs appear to potentiate the action of traditional therapeutics, often by demethylating and re-expressing tumor suppressor genes to inhibit tumorigenesis. Epigenetic drugs may inhibit both the formation and growth of cancer progenitor cells, thus reducing the recurrence of cancer. Adopting epigenetic alteration as a new hallmark of cancer is a logical and necessary step that will further encourage the development of novel epigenetic biomarkers and therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 1×
“IDH1/IDH2 downregulation or mutation has been reported in chondrosarcoma [42], enchondroma [42,43], glioma [44], melanoma [39], and thyroid carcinoma [45,46].”
BackgroundConversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · cited 1×
“(5mC) to 5hmC [26].”
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · cited 1×
“Perhaps it is not surprising then, that in many tumors, HDACs 1, 2, and 6 are overexpressed [22].”
BackgroundTet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y.-F., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,770
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776 · cited 2×
“A TET1 fusion with histone methyltransferase mixed-lineage leukemia (MLL) has also been identified in several cases of AML [35,36].”
BackgroundEpithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain
Guo, J. U., Su, Y., Zhong, C., Ming, G.-L., & Song, H. (2011) · Cell · doi:10.1016/j.cell.2011.03.022 · Cited by 1,360
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes
Gu, T.-P., Guo, F., Yang, H., Wu, H.-P., Xu, G.-F., Liu, W., Xie, Z.-G., Shi, L., He, X., Jin, S.-G., et al. (2011) · Nature · doi:10.1038/nature10443 · Cited by 1,139
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119
Autophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., Egan, D. A., Li, A., Huang, G., Klein-Szanto, A. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1681 · Cited by 975
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2021 · Cited by 937
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · cited 1×
“Chemotherapeutics make use of similar apoptotic mechanisms to target cancer cells for death [64].”
BackgroundThymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine
Maiti, A., & Drohat, A. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.284620 · Cited by 828
Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano, D., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.020 · Cited by 809
5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming
Wossidlo, M., Nakamura, T., Lepikhov, K., Marques, C. J., Zakhartchenko, V., Boiani, M., Arand, J., Nakano, T., Reik, W., & Walter, J. (2011) · Nature Communications · doi:10.1038/ncomms1240 · Cited by 792
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.033 · Cited by 789
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · cited 1×
“A knockdown study of glioblastoma cells exhibiting high miR-21 levels demonstrated that miR-21 controls p53-mediated apoptosis and cell growth and leads to cell cycle arrest [79].”
BackgroundIqbal, K., Jin, S.-G., Pfeifer, G. P., & Szabó, P. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014033108 · Cited by 692
Juergens, R. A., Wrangle, J., Vendetti, F. P., Murphy, S. C., Zhao, M., Coleman, B., Sebree, R., Rodgers, K., Hooker, C. M., Franco, N., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0214 · Cited by 686
Acquired mutations in TET2 are common in myelodysplastic syndromes
Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 680
The PIK3CA gene is mutated with high frequency in human breast cancers
Bachman, K. E., Argani, P., Samuels, Y., Silliman, N., Ptak, J., Szabo, S., Konishi, H., Karakas, B., Blair, B. G., Lin, C., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.8.994 · Cited by 665
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glöckner, S., Piantadosi, S., Gabrielson, E., Pridham, G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706550 · Cited by 593
Yang, H., Liu, Y., Bai, F., Zhang, J.-Y., Ma, S.-H., Liu, J., Xu, Z.-D., Zhu, H.-G., Ling, Z.-Q., Ye, D., et al. (2013) · Oncogene · doi:10.1038/onc.2012.67 · Cited by 574
Pansuriya, T. C., van Eijk, R., d'Adamo, P., van Ruler, M. A. J. H., Kuijjer, M. L., Oosting, J., Cleton-Jansen, A.-M., van Oosterwijk, J. G., Verbeke, S. L. J., Meijer, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.1004 · Cited by 559
Cheng, G. Z., Chan, J., Wang, Q., Zhang, W., Sun, C. D., & Wang, L.-H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1479 · Cited by 546
Phosphoinositide 3-kinase signalling pathways
Cantrell, D. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1439 · Cited by 533
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Sánchez-Tilló, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A., & Postigo, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1122-2 · Cited by 518
Song, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K., Ng, C., Beringer, G., Brikbak, N. J., Yuan, X., Cantley, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.026 · Cited by 491
Selectins promote tumor metastasis
Läubli, H., & Borsig, L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.005 · Cited by 461
Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins
Bendas, G., & Borsig, L. (2012) · International Journal of Cell Biology · doi:10.1155/2012/676731 · Cited by 458
Yildirim, O., Li, R., Hung, J.-H., Chen, P. B., Dong, X., Ee, L.-S., Weng, Z., Rando, O. J., & Fazzio, T. G. (2011) · Cell · doi:10.1016/j.cell.2011.11.054 · Cited by 450
Phosphoinositide 3-kinase signalling pathways
Domin, J. (2006) · Phosphoinositide 3-Kinase Signalling Pathway · doi:10.1142/9781860948091_0003 · Cited by 444
Cysteine Cathepsins and the Cutting Edge of Cancer Invasion
Gocheva, V., & Joyce, J. A. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3669 · Cited by 437
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
Amary, M. F., Damato, S., Halai, D., Eskandarpour, M., Berisha, F., Bonar, F., McCarthy, S., Fantin, V. R., Straley, K. S., Lobo, S., et al. (2011) · Nature Genetics · doi:10.1038/ng.994 · Cited by 428
Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
Barkan, D., Kleinman, H., Simmons, J. L., Asmussen, H., Kamaraju, A. K., Hoenorhoff, M. J., Liu, Z.-Y., Costes, S. V., Cho, E. H., Lockett, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6849 · Cited by 425
Haffner, M. C., Chaux, A., Meeker, A. K., Esopi, D. M., Gerber, J., Pellakuru, L. G., Toubaji, A., Argani, P., Iacobuzio-Donahue, C., Nelson, W. G., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.316 · Cited by 423
Lorsbach, R. B., Moore, J., Mathew, S., Raimondi, S. C., Mukatira, S. T., & Downing, J. R. (2003) · Leukemia · doi:10.1038/sj.leu.2402834 · Cited by 416
Fang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., & Yang, C. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0406 · Cited by 410
Taby, R., & Issa, J.-P. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20085 · Cited by 407
Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., & Moses, H. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106176200 · Cited by 388
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation
Rothbart, S. B., Krajewski, K., Nady, N., Tempel, W., Xue, S., Badeaux, A. I., Barsyte-Lovejoy, D., Martinez, J. Y., Bedford, M. T., Fuchs, S. M., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2391 · Cited by 378
Anti- and pro-tumor functions of autophagy
Morselli, E., Galluzzi, L., Kepp, O., Vicencio, J.-M., Criollo, A., Maiuri, M. C., & Kroemer, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.006 · Cited by 375
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
Ko, M., An, J., Bandukwala, H. S., Chavez, L., Äijö, T., Pastor, W. A., Segal, M. F., Li, H., Koh, K. P., Lähdesmäki, H., et al. (2013) · Nature · doi:10.1038/nature12052 · Cited by 373
Fas death receptor signalling: roles of Bid and XIAP
Kaufmann, T., Strasser, A., & Jost, P. J. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.121 · Cited by 373
Shibue, T., & Weinberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904227106 · Cited by 364
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S.-O., Du, Y., Wang, Y., Chang, W.-C., Chen, C.-H., et al. (2013) · Nature · doi:10.1038/nature12080 · Cited by 356
Role of microRNAs in drug-resistant ovarian cancer cells
Sorrentino, A., Liu, C.-G., Addario, A., Peschle, C., Scambia, G., & Ferlini, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.017 · Cited by 354
Lombaerts, M., van Wezel, T., Philippo, K., Dierssen, J. W. F., Zimmerman, R. M. E., Oosting, J., van Eijk, R., Eilers, P. H., van de Water, B., Cornelisse, C. J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602996 · Cited by 346
Cytosine methylation determines hot spots of DNA damage in the human P 53 gene
Denissenko, M. F., Chen, J. X., Tang, M.-S., & Pfeifer, G. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3893 · Cited by 339
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Catto, J. W. F., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., Larré, S., Milo, M., Rehman, I., Rosario, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0744 · Cited by 329
Song, S. J., Ito, K., Ala, U., Kats, L., Webster, K., Sun, S. M., Jongen-Lavrencic, M., Manova-Todorova, K., Teruya-Feldstein, J., Avigan, D. E., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.06.003 · Cited by 326
Mechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 317
Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia
Blum, W., Klisovic, R. B., Hackanson, B., Liu, Z., Liu, S., Devine, H., Vukosavljevic, T., Huynh, L., Lozanski, G., Kefauver, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4169 · Cited by 315
Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA
Zhang, L., Lu, X., Lu, J., Liang, H., Dai, Q., Xu, G.-L., Luo, C., Jiang, H., & He, C. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.914 · Cited by 299
Zhang, Y., Li, M., Wang, H., Fisher, W. E., Lin, P. H., Yao, Q., & Chen, C. (2009) · World Journal of Surgery · doi:10.1007/s00268-008-9833-0 · Cited by 298
Nass, S. J., Herman, J. G., Gabrielson, E. W., Iversen, P. W., Parl, F. F., Davidson, N. E., & Graff, J. R. (2000) · PubMed · Cited by 292
Ono, R., Taki, T., Taketani, T., Taniwaki, M., Kobayashi, H., & Hayashi, Y. (2002) · PubMed · Cited by 278
Cancer Epigenetics: Modifications, Screening, and Therapy
Einav Nili, G.-Y., Saito, Y., Egger, G., & Jones, P. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061606.095816 · Cited by 270
Battula, V. L., Evans, K. W., Hollier, B. G., Shi, Y., Marini, F. C., Ayyanan, A., Wang, R.-Y., Brisken, C., Guerra, R., Andreeff, M., et al. (2010) · Stem Cells · doi:10.1002/stem.467 · Cited by 266
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
Lamouille, S., Subramanyam, D., Blelloch, R., & Derynck, R. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.008 · Cited by 259
Lee, J. H., Khor, T. O., Shu, L., Su, Z.-Y., Fuentes, F., & Kong, A.-N. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.008 · Cited by 247
Galliher, A. J., & Schiemann, W. P. (2006) · Breast Cancer Research · doi:10.1186/bcr1524 · Cited by 236
Wyman, S. K., Parkin, R. K., Mitchell, P. S., Fritz, B. R., O'Briant, K., Godwin, A. K., Urban, N., Drescher, C. W., Knudsen, B. S., & Tewari, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005311 · Cited by 233
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
Nagaraja, A. K., Creighton, C. J., Yu, Z., Zhu, H., Gunaratne, P. H., Reid, J. G., Olokpa, E., Itamochi, H., Ueno, N. T., Hawkins, S. M., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0295 · Cited by 230
Comprehensive microRNA Profiling of Prostate Cancer
Walter, B. A., Valera, V. A., Pinto, P. A., & Merino, M. J. (2013) · Journal of Cancer · doi:10.7150/jca.6394 · Cited by 225
Estève, P.-O., Chang, Y., Samaranayake, M., Upadhyay, A. K., Horton, J. R., Feehery, G. R., Cheng, X., & Pradhan, S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1939 · Cited by 220
Paschos, K. A., Canovas, D., & Bird, N. C. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.006 · Cited by 206
Robertson, K. D. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.10.2108 · Cited by 199
Wendt, M. K., Smith, J. A., & Schiemann, W. P. (2010) · Oncogene · doi:10.1038/onc.2010.377 · Cited by 197
Recognition of 5-Hydroxymethylcytosine by the Uhrf1 SRA Domain
Frauer, C., Hoffmann, T., Bultmann, S., Casa, V., Cardoso, M. C., Antes, I., & Leonhardt, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021306 · Cited by 180
Diederichs, S., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0537 · Cited by 176
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer
Hannafon, B. N., Sebastiani, P., de las Morenas, A., Lu, J., & Rosenberg, C. L. (2011) · Breast Cancer Research · doi:10.1186/bcr2839 · Cited by 171
Zhou, Q., Agoston, A. T., Atadja, P., Nelson, W. G., & Davidson, N. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0330 · Cited by 167
In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling
Miller, P. G., Al-Shahrour, F., Hartwell, K. A., Chu, L. P., Järås, M., Puram, R. V., Puissant, A., Callahan, K. P., Ashton, J., McConkey, M. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.004 · Cited by 166
Horak, P., Pils, D., Haller, G., Pribill, I., Roessler, M., Tomek, S., Horvat, R., Zeillinger, R., Zielinski, C. C., & Krainer, M. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0136 · Cited by 164
Liu, C., Liu, L., Chen, X., Shen, J., Shan, J., Xu, Y., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062828 · Cited by 163
The epigenetics of ovarian cancer drug resistance and resensitization
Balch, C., Huang, T. H.-M., Brown, R., & Nephew, K. P. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.05.025 · Cited by 160
Wendt, M. K., & Schiemann, W. P. (2009) · Breast Cancer Research · doi:10.1186/bcr2360 · Cited by 158
The selectin–selectin ligand axis in tumor progression
Witz, I. P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9101-z · Cited by 157
Frew, A. J., Lindemann, R. K., Martin, B. P., Clarke, C. J. P., Sharkey, J., Anthony, D. A., Banks, K.-M., Haynes, N. M., Gangatirkar, P., Stanley, K. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801868105 · Cited by 155
Nakata, K., Ohuchida, K., Mizumoto, K., Kayashima, T., Ikenaga, N., Sakai, H., Cui, L., Fujita, H., Otsuka, T., Aishima, S., et al. (2011) · Surgery · doi:10.1016/j.surg.2011.06.017 · Cited by 149
MicroRNAs in ovarian cancer biology and therapy resistance
van Jaarsveld, M. T. M., Helleman, J., Berns, E. M. J. J., & Wiemer, E. A. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.014 · Cited by 148
Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.
Sarkar, S., Abujamra, A. L., Loew, J. E., Forman, L. W., Perrine, S. P., & Faller, D. V. (2011) · PubMed · Cited by 143
Self-citationMurugan, A. K., Bojdani, E., & Xing, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.095 · Cited by 142
Watson, M. A., Ylagan, L. R., Trinkaus, K. M., Gillanders, W. E., Naughton, M. J., Weilbaecher, K. N., Fleming, T. P., & Aft, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0024 · Cited by 127
The significance of epigenetic alterations in lung carcinogenesis
Brzeziańska‐Lasota, E., Dutkowska, A., & Antczak, A. J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2063-4 · Cited by 109
A microRNA expression ratio defining the invasive phenotype in bladder tumors
Neely, L. A., Rieger‐Christ, K., Neto, B. S., Eroshkin, A. M., Garver, J., Patel, S. A., Phung, N. A., McLaughlin, S., Libertino, J. A., Whitney, D. H., et al. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.06.006 · Cited by 108
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
Matei, D. E., & Nephew, K. P. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.09.043 · Cited by 106
Piccolo, F. M., Bagci, H., Brown, K. E., Landeira, D., Soza-Ried, J., Feytout, A., Mooijman, D., Hájková, P., Leitch, H. G., Tada, T., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.032 · Cited by 103
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancerPreprint
Matsumura, N., Huang, Z., Mori, S., Baba, T., Fujii, S., Konishi, I., Iversen, E. S., Berchuck, A., & Murphy, S. K. (2010) · Genome Research · doi:10.1101/gr.108803.110 · Cited by 95
Laufs, S., Schumacher, J., & Allgayer, H. (2006) · Cell Cycle · doi:10.4161/cc.5.16.2994 · Cited by 93
TGF-β1 regulates cell fate during epithelial–mesenchymal transition by upregulating survivin
Lee, J., Choi, J., & Joo, C.-K. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.244 · Cited by 90
miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
Shen, Y., Wang, P., Li, Y., Ye, F., Wang, F., Wan, X., Cheng, X., Lü, W., & Xie, X. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.308 · Cited by 87
Gandellini, P., Profumo, V., Casamichele, A., Fenderico, N., Borrelli, S., Petrovich, G., Santilli, G., Callari, M., Colecchia, M., Pozzi, S., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.56 · Cited by 87
Federico, A., Pallante, P., Bianco, M., Ferraro, A., Esposito, F., Monti, M., Cozzolino, M., Keller, S., Fedele, M., Leone, V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1542 · Cited by 84
Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas
Hemerly, J. P., Bastos, A. U., & Cerutti, J. M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0473 · Cited by 84
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor
Sánchez‐González, B., Yang, H., Bueso-Ramos, C., Hoshino, K., Quintás‐Cardama, A., Richon, V. M., & Garcia‐Manero, G. (2006) · Blood · doi:10.1182/blood-2005-09-008086 · Cited by 82
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer
Ulazzi, L., Sabbioni, S., Miotto, E., et al. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-17 · Cited by 81
Neureiter, D., Zopf, S., Leu, T., Dietze, O., Hauser‐Kronberger, C., Hahn, E. G., Herold, C., & Ocker, M. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600874198 · Cited by 77
Blick, C., Ramachandran, A., Wigfield, S., McCormick, R. D., Jubb, A. M., Buffa, F. M., Turley, H., Knowles, M. A., Cranston, D., Catto, J. W. F., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.240 · Cited by 70
Fujii, S., Luo, R. Z., Yuan, J., Kadota, M., Oshimura, M., Dent, S., Kondo, Y., Issa, J. J., Bast, R. C., & Yu, Y. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg204 · Cited by 64
Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
Zuo, T., Liu, T.-M., Lan, X., Weng, Y., Shen, R. Z., Gu, F., Huang, Y., Liyanarachchi, S., Deatherage, D. E., Hsu, P.-Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3573 · Cited by 63
Nejjari, M., Hafdi‐Nejjari, Z., Gouysse, G., Fiorentino, M., Béatrix, O., Dumortier, J., Pourreyron, C., Barozzi, C., D’Errico, A., Grigioni, W. F., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.34611 · Cited by 63
Cancer Prevention: Epigenetics Steps Up to the Plate
Issa, J. J. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0029 · Cited by 62
Sarkar, S., Goldgar, S., Byler, S., Rosenthal, S., & Heerboth, S. A. (2013) · Epigenomics · doi:10.2217/epi.12.68 · Cited by 62
Self-citationImpaired Retinoic Acid (RA) Signal Leads to RARβ2 Epigenetic Silencing and RA Resistance
Ren, M., Pozzi, S., Bistulfi, G. L., Somenzi, G., Rossetti, S., & Sacchi, N. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10591-10603.2005 · Cited by 61
Ab, G., Leyland-Jones, B., Hg, C., Davies, B., & Df, H. (1987) · PubMed · Cited by 56
Xu, S., Li, W., Zhu, J., Wang, R., Li, Z., Xu, G., & Ding, J. (2013) · Cell Research · doi:10.1038/cr.2013.107 · Cited by 55
Aberrant methylation of integrin α4 gene in human gastric cancer cells
Park, J., Song, S., Kim, T. Y., Choi, M.-C., Jong, H.-S., Kim, T., Lee, S. E., Kim, N. K., Kim, W. H., & Bang, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207470 · Cited by 53
Liang, K., Lü, Y., Li, X., Zeng, X., Glazer, R. I., Mills, G. B., & Fan, Z. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023333 · Cited by 50
Akt2: a role in breast cancer metastasis
Chau, N., & Ashcroft, M. A. (2003) · Breast Cancer Research · doi:10.1186/bcr739 · Cited by 47
Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor.
Mataga, M. A., Rosenthal, S., Heerboth, S., Devalapalli, A., Kokolus, S., Evans, L. R., Longacre, M. M., Housman, G., & Sarkar, S. (2012) · PubMed · Cited by 44
Self-citationT-Oligos Inhibit Growth and Induce Apoptosis in Human Ovarian Cancer Cells
Sarkar, S., & Faller, D. V. (2011) · Oligonucleotides · doi:10.1089/oli.2010.0259 · Cited by 42
Self-citationPosttranslational Truncation of E-Cadherin \nand Significance for Tumour Progression
Masterson, J. C., & O’Dea, S. (2007) · Maynooth University ePrints and eTheses Archive (Maynooth University) · Cited by 41
Co-opted integrin signaling in ErbB2-induced mammary tumor progression
Carraway, K. L., & Sweeney, C. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.015 · Cited by 24
FLIP: A flop for execution signals
Subramaniam, K., Hirpara, J. L., Tucker‐Kellogg, L., Tucker‐Kellogg, G., & Pervaiz, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.005 · Cited by 23
鶴谷, 純. (2009) · Mebio oncology · Cited by 22
Sarkar, S., Svoboda, M., de Beaumont, R., et al. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000003009 · Cited by 22
Self-citationDong, Z., Guo, W., Guo, Y., Kuang, G., & Yang, Z. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182253430 · Cited by 20
Sarkar, S., & Faller, D. V. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0401 · Cited by 18
Self-citation
Cited by
Drug resistance in cancer: An overview
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014) · Cancers · doi:10.3390/cancers6031769 · Cited by 2,463
Self-citationArsenic and human health effects: A review
Mohammed Abdul, K. S., Jayasinghe, S. S., Chandana, E. P. S., Jayasumana, C., & De Silva, P. M. C. S. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.09.016 · Cited by 907
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
Self-citationIn vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
Epigenetic drivers of tumourigenesis and cancer metastasis
Chatterjee, A., Rodger, E. J., & Eccles, M. R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.004 · Cited by 328
Metadata
- Authors
- Sarkar, S., Horn, G., Moulton, K., Oza, A., Byler, S., Kokolus, S., & Longacre, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2013-10-21
- Volume
- 14
- Issue
- 10
- Pages
- 21087-21113
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2068164877
- Cited by
- 386
- References
- 152
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.